479 related articles for article (PubMed ID: 16732582)
1. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
2. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
3. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
4. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
5. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
Davidson DF; Hammond PJ; Murphy D; Carachi R
Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
[TBL] [Abstract][Full Text] [Related]
6. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
[TBL] [Abstract][Full Text] [Related]
7. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
Tuchman M; Ramnaraine ML; Woods WG; Krivit W
Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of vanillylmandellic acid in neuroblastoma.
Aydin GB; Kutluk MT; Yalcin B; Varan A; Akyuz C; Buyukpamukcu M
Pediatr Hematol Oncol; 2010 Sep; 27(6):435-48. PubMed ID: 20578806
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
[TBL] [Abstract][Full Text] [Related]
10. Hormonal activity may predict aggressive behavior in neuroblastoma.
Zambrano E; Reyes-Múgica M
Pediatr Dev Pathol; 2002; 5(2):190-9. PubMed ID: 11910515
[TBL] [Abstract][Full Text] [Related]
11. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
[TBL] [Abstract][Full Text] [Related]
12. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.
Barco S; Gennai I; Reggiardo G; Galleni B; Barbagallo L; Maffia A; Viscardi E; De Leonardis F; Cecinati V; Sorrentino S; Garaventa A; Conte M; Cangemi G
Clin Biochem; 2014 Jun; 47(9):848-52. PubMed ID: 24769278
[TBL] [Abstract][Full Text] [Related]
13. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
[TBL] [Abstract][Full Text] [Related]
14. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
Tuchman M; Stoeckeler JS
Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
[TBL] [Abstract][Full Text] [Related]
15. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
[TBL] [Abstract][Full Text] [Related]
16. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.
Verly IR; van Kuilenburg AB; Abeling NG; Goorden SM; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GL; Merks JH; Caron HN; Tytgat GA
Eur J Cancer; 2017 Feb; 72():235-243. PubMed ID: 28061374
[TBL] [Abstract][Full Text] [Related]
17. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of homovanillic acid (HVA) and vanillylmandelic acid (VMA) in urine using gas chromatography-mass spectrometry (GC/MS).
Allenbrand R; Garg U
Methods Mol Biol; 2010; 603():261-9. PubMed ID: 20077077
[TBL] [Abstract][Full Text] [Related]
19. Excretion of catecholamines in relatives of patients with familial neuroblastoma.
Piöchl E; Käser H; Klein H
Cancer Res; 1976 Jan; 36(1):10-12. PubMed ID: 1247989
[TBL] [Abstract][Full Text] [Related]
20. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
